AOXING PHARMACEUTICAL COMPANY, INC. Financing Receivable, after Allowance for Credit Loss
AOXING PHARMACEUTICAL COMPANY, INC. had Financing Receivable, after Allowance for Credit Loss of $781.98 thousand as of 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Balance Sheet › Assets
us-gaap:NotesReceivableNet · last filed 2017-05-15
- 2017-03-31: Financing Receivable, after Allowance for Credit Loss $781.98K.
- 2016-12-31: Financing Receivable, after Allowance for Credit Loss $792.39K.
- 2016-09-30: Financing Receivable, after Allowance for Credit Loss $1.23M.
- 2016-06-30: Financing Receivable, after Allowance for Credit Loss $765.32K.
| Period end | Financing Receivable, after Allowance for Credit Loss |
|---|---|
| 2017-03-31 | $781.98K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $792.39K 10-Q · filed 2017-02-17 |
| 2016-09-30 | $1.23M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $765.32K 10-Q · filed 2017-05-15 |
| 2016-03-31 | $16.68K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $23.10K 10-Q · filed 2016-02-08 |
| 2015-06-30 | $89.32K 10-Q · filed 2016-05-16 |